For instance, while germline mutations in human BRCA2 are known to predispose for breast and ovarian cancer, recently, evidence was presented suggesting that mutations in the BRCA pathway also significantly increase the risk for certain leukaemias and lymphomas35. This evidence concerns the gene BRCA2 and ovarian carcinoma.